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Bruce J MayerAnthony J PawsonThe scientific community was deeply saddened by news
of the untimely death of Tony Pawson, a member of the
BMC Biology editorial board and a leader in the field of
cell signaling. I first met Tony when I was a graduate
student in the 1980s, at one of those summer research
meetings where science was followed by beer and con-
versation. I still have vivid memories of Tony, with his
shock of white hair and ready smile, chatting into the
night with students and other colleagues about his
current passion, an obscure tyrosine kinase called Fps.
Tony exemplified the investigators working on onco-
genes at the time - smart, collegial, and burning to
understand how cell signaling worked and how it could
go so terribly wrong in cancer. In a few short years Tony
emerged from this group to become one of the most in-
fluential biologists of the past two decades, shaping the
new field of cell signaling.
To understand the significance of Tony’s contributions,
we need to think back to how little was known at that
time. We knew that unrestrained tyrosine kinase activity
could stimulate cells to proliferate, and that the receptors
for mitogens such as epidermal growth factor and
platelet-derived growth factor also had tyrosine kinase ac-
tivity. These kinases seemed to work by somehow activat-
ing additional signaling proteins such as the G protein Ras
and serine/threonine kinases, but we knew almost nothing
about the mechanism. How were tyrosine kinases regu-
lated, and how did they transmit downstream signals?
How could these mechanisms be subverted in cancer?
Tony’s lab at the time was focused on Fps, which like its
much more celebrated cousin, Src, was an oncogenic tyro-
sine kinase first identified in an avian sarcoma virus.
Tony’s group was interested in what caused the activity of
the oncogenic kinases to be unregulated compared with
that of their unmutated cellular counterparts, and he zer-
oed in on a region N-terminal to the catalytic domain. In
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the term ‘SH2 domain’ for this region, for Src Homology
domain 2 - a second region of sequence similarity between
Fps and Src, the first being the tyrosine kinase catalytic
domain. Soon such ‘homology domains’ began popping
up in more and more signaling proteins as they were
cloned and sequenced - Ras-GAP, phospholipase C, phos-
phatidylinositol 3-kinase, and the small oncogenic protein
Crk, which seemed to consist of little else. Clearly these
small regions had a powerful influence and were widely
used in cell signaling, but how might they work?
Taking full advantage of new and improved research
tools as they became available (bacterial fusion proteins,
X-ray crystallography and NMR spectroscopy, genetic
models, high-throughput screening methods), Tony’s
group and others quickly demonstrated that SH2 domains
bound to specific tyrosine-phosphorylated peptides and
thus served to relocalize cytosolic effector proteins
containing SH2 domains to the membrane upon activa-
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specific interactions with other peptides or lipids. These
discoveries were quite stunning at the time, hinting at an
entirely new and unexpected paradigm for signaling. But
beyond the mere details of mechanism, Tony was the one
who saw the bigger picture most clearly - the fundamental
importance of protein-protein interactions and subcellular
localization as essential currencies of information transfer.
He also saw how modular protein and lipid interaction do-
mains provided a credible means for signal transduction
pathways to emerge and gain new functions in the course
of evolution. More than anyone else, Tony made sense of
the new discoveries and revealed the underlying logic for
all to see.
It is hard to overstate the excitement of those times.
The answers to big, important questions came tumbling
out one after the other, as disparate pieces of evidence
from the fields of biochemistry, genetics, virology, and de-
velopmental biology began to fit together in a profoundly
satisfying way. And through it all Tony led the way -
through the work of his lab, through his beautifully writ-
ten and deeply insightful review articles, and through his
willingness to share what he knew with his colleagues.
In the decades that followed these initial discoveries,
most of those involved moved on, or focused on ever-
smaller pieces of the puzzle. By contrast, Tony took on
the more challenging task of building on those results
on a grand scale. In his position as director of the
Lunenfeld Research Institute in Toronto, he worked to
assemble large interdisciplinary teams that were needed
to tackle the questions he wanted to address. He was a
pioneer in incorporating emerging disciplines and tech-
nologies such as bioinformatics and mass spectrometry
into signaling research. In short, he made Toronto the
center of the signaling universe. He had a big vision and
the skills, energy, and intellect to pursue that vision,
probably better than anyone else in the field.
While Tony’s scientific accomplishments were im-
mense, they cannot explain why so many of us will miss
him so keenly. Above all, Tony was a wonderful col-
league and friend. I can personally attest that he was al-
ways far kinder to me than I had any reason to expect,
given my position as a junior investigator directly com-
peting with his lab. He provided wise advice, shared his
lab’s results before publication, collaborated when pos-
sible, and gladly acknowledged and appreciated the work
of others. He was a genuinely selfless and humble man,
terms that are not often associated with scientists of
Tony’s stature. Although he was aware of his own ac-
complishments, he never let it go to his head (he loved
to point out that he had been awarded the Noble Prize -
a relatively obscure Canadian research award - knowing
full well that he was perennially touted as a shoo-in for
the more celebrated Swedish prize).I got to know Tony better in recent years as we worked
together on a textbook of cell signaling. The clarity of his
vision and his comprehensive knowledge of the field were
the solid foundation upon which the book is built. Sadly,
personal tragedies, particularly the wrenching loss of his
beloved wife Maggie to cancer, made it more difficult for
Tony to focus on science in the past few years. It is a re-
minder that despite our talents, accomplishments, and es-
sential goodness, we all live close to the edge of disaster.
But although we lost Tony far too soon, we can still take
joy in all that he accomplished while he was with us: the
many trainees, colleagues and friends whose lives he
touched, the new insights and discoveries he brought to
light, the institutions and ideas that he fostered. Many of
us will feel that the world is a far better place because of
Tony Pawson.
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